CD152/CTLA-4 secondary antibody product blog
Tags: Secondary Antibody; CD152/CTLA-4; CD152/CTLA-4 secondary antibody;
The CD152/CTLA-4 n/a (Catalog #MBS673518) is an Antibody produced from Syrian Hamster and is intended for research purposes only. The product is available for immediate purchase. The Hamster Anti-Mouse CD152/CTLA-4-UNLB reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s CD152/CTLA-4 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry; Immunoprecipitation.Research Application(s): In vitro and in vivo blocking of CTLA-4 action by soluble antibody
Promotion of in vitro CTLA-4 signalling by cross-linked antibody
Flow Cytometry Suggested Dilution: <= 3 ug/10^6 cells. Researchers should empirically determine the suitability of the CD152/CTLA-4 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Heat-killed Staphylococcus A bacteria coated with mouse CTLA-4/human IgG1 fusion protein. Characterization: To insure acceptable performance, each batch of product is tested by flow cytometry to conform to characteristics of a standard reference reagent. Representative data are included in this product insert. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD152/CTLA-4 are readily searchable from our website. Different antibodies against the same target such as CD152/CTLA-4 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.